Form D · Biotechnology
Archean Sciences, Inc.
Champaign, IL · CIK 0002150107
Offering snapshot reported Aug 13, 2026 · SEC filing
- Reported sold
- $385K Indefinite offering
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- May 27, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 13, 2026 | Initial | $385,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-594195
Simple Agreement for Future Equity (SAFE)
Source: Form D, filed Aug 13, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Austin Russell Ellis Mohr | Director, Executive |
| Mattia Gazzola | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
60 Hazelwood Dr
Champaign, IL, 61820
Phone: 7167255155
Champaign, IL, 61820
Phone: 7167255155